Exhibit 23

                          Independent Auditors' Consent

The Board of Directors
Unigene Laboratories, Inc:

We consent to the incorporation by reference in the registration statements (No.
333-60642 and 333-75960) on Form S-1, the registration statements (Nos.
333-04557, 333-18079, 333-43439 and 333-63245) on Form S-3 and the registration
statements (Nos. 33-18890, 333-52376, 333-01897 and 333-35951) on Form S-8 of
Unigene Laboratories, Inc. of our report dated March 29, 2002, except as to the
last paragraph of Note 7, which is as of April 9, 2002, with respect to the
balance sheets of Unigene Laboratories, Inc. as of December 31, 2001 and 2000,
and the related statements of operations, stockholders' equity (deficit), and
cash flows for each of the years in the three-year period ended December 31,
2001, which report appears in the December 31, 2001 annual report on Form 10-K
of Unigene Laboratories, Inc. Our report dated March 29, 2002, except as to the
last paragraph of Note 7, which is as of April 9, 2002, contains an explanatory
paragraph that states that Unigene Laboratories, Inc. has suffered recurring
losses from operations and has a working capital deficiency which raise
substantial doubt about its ability to continue as a going concern. The
financial statements do not include any adjustments that might result from the
outcome of that uncertainty. Also, our report refers to a change in the method
of accounting for revenue recognition for up-front, non-refundable license fees
in 2000.

/s/ KPMG LLP


Short Hills, New Jersey
April 11, 2002